Sensitive quantitation of reboxetine enantiomers in rat plasma and brain, using an optimised reverse phase chiral

Paul Turnpenny1, Daniela Fraier

  • 1Discovery Bioanalytical Group, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Sandwich, Kent CT13 9NJ, UK. paul.turnpenny@pfizer.com

Related Concept Videos